Rate this Article: A Comparative Evaluation of Efficacy of 1.2% Atorvastatsin and 1.2% of Rosuvastatsin with Platelet Rich Fibrin in Intaosseous Alveolar Defects: A Randomized Clinical Trial

Rating (1-10):

1

Comments (ART20203609):

Please enter 100–200 characters. 0/200 characters

Full Name: Email Address (Important: You will receive Rating Verification Link on this Email Address):

Leave this field empty

Back to Article